ONCODESIGN
ALONC | PA
Overview
Corporate Details
- ISIN(s):
- FR0011766229
- LEI:
- 9695004HPDBVG72O8851
- Country:
- France
- Address:
- 20 RUE JEAN MAZEN, 21000 DIJON
- Website:
- https://www.oncodesign.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Oncodesign Precision Medicine (OPM) is a biopharmaceutical company specializing in precision medicine to combat cancer. The company's core mission is to discover and develop innovative therapeutic and diagnostic solutions targeting therapeutic resistance and metastasis. OPM utilizes a patient-centric, translational approach, from AI-driven target identification to the clinical development of its proprietary drug pipeline. The company focuses on addressing critical unmet medical needs in oncology by translating scientific discoveries into effective treatments for patients.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for ONCODESIGN.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2022-12-13 14:25 |
Delisting Announcement
Communiqués publiés en période d'offre publique d'acquisition / OPA Autres comm…
|
French | 150.7 KB | |
| 2022-12-13 11:17 |
Major Shareholding Notification
Franchissement de seuils
|
French | 209.0 KB | |
| 2022-11-24 08:00 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 145.1 KB | |
| 2022-11-23 17:37 |
Prospectus
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 724.9 KB | |
| 2022-11-23 17:36 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 2.3 MB | |
| 2022-11-08 16:38 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 2.2 MB | |
| 2022-11-08 15:54 |
Delisting Announcement
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 231.6 KB | |
| 2022-11-02 17:28 |
Prospectus
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 1.0 MB | |
| 2022-11-02 17:25 |
Prospectus
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 506.0 KB | |
| 2022-10-26 11:17 |
Major Shareholding Notification
Franchissement de seuil
|
French | 198.3 KB | |
| 2022-10-26 11:16 |
Major Shareholding Notification
Franchissement de seuils
|
French | 206.0 KB | |
| 2022-10-19 08:00 |
M&A Activity
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | 340.5 KB | |
| 2022-10-19 08:00 |
M&A Activity
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 390.8 KB | |
| 2022-10-04 18:00 |
Delisting Announcement
Inside Information / Other news releases
|
English | 268.6 KB | |
| 2022-10-04 18:00 |
Delisting Announcement
Informations privilégiées / Autres communiqués
|
French | 273.9 KB |
Automate Your Workflow. Get a real-time feed of all ONCODESIGN filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ONCODESIGN via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
